4basebio PLC (LON:4BB - Get Free Report) shares traded up 1.2% on Tuesday . The stock traded as high as GBX 850 ($11.45) and last traded at GBX 850 ($11.45). 472 shares were traded during mid-day trading, a decline of 60% from the average session volume of 1,181 shares. The stock had previously closed at GBX 840 ($11.32).
4basebio Stock Down 3.9%
The company has a quick ratio of 3.52, a current ratio of 2.73 and a debt-to-equity ratio of 201.47. The company has a market capitalization of £123.88 million, a P/E ratio of -851.06 and a beta of 1.09. The firm has a 50-day moving average price of GBX 914.50 and a two-hundred day moving average price of GBX 1,033.44.
About 4basebio
(
Get Free Report)
4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.
Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients.
Recommended Stories
Before you consider 4basebio, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 4basebio wasn't on the list.
While 4basebio currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
